Results 121 to 130 of about 416,692 (196)

Epidemiologic and Genomic Surveillance of Vibrio cholerae and Effectiveness of Single-Dose Oral Cholera Vaccine, Democratic Republic of the Congo. [PDF]

Emerg Infect Dis
George CM, Namunesha A, Endres K, Felicien W, Sanvura P, Bisimwa JC, Perin J, Bengehya J, Kulondwa JC, Maheshe G, Cikomola C, Bisimwa L, Mwishingo A, Sack DA, Domman D.   +14 more
europepmc   +1 more source

Cholera vaccine.

MMWR. Morbidity and mortality weekly report, 1988
openaire   +3 more sources

Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023. [PDF]

Clin Infect Dis
Edosa M, Jeon Y, Gedefaw A, Hailu D, Mesfin Getachew E, Mogeni OD, Jang GH, Mukasa D, Yeshitela B, Getahun T, Lynch J, Bouhenia M, Worku Demlie Y, Hussen M, Wossen M, Teferi M, Park SE.   +16 more
europepmc   +1 more source

Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019-2020 targeted preventative mass campaigns. [PDF]

Vaccine X
Briskin E, Bateyi Mustafa SH, Mahamba R, Kabunga D, Kubuya J, Porten K, Epicentre-MSF DRC cholera working group, Akilimali L, Okitayemba Welo P, Broban A.   +9 more
europepmc   +1 more source

Knowledge and perception of a clinical trial among the participants: An experience from oral cholera vaccine study in Koshi Province, Nepal. [PDF]

Hum Vaccin Immunother
Chaudhary S, Uranw S, Rai B, Keshary Bhatta N, Shah GS, Poudel P, Khanal B, Shah Kalawar RP, Rai N, Shrestha J, Shrestha M, Parajuli S, Gupta BP, Vemula S, Rok Song K, Lynch J, Saluja T.   +16 more
europepmc   +1 more source

Do Oral Cholera Vaccine and Water, Sanitation, and Hygiene Combine to Provide Greater Protection Against Cholera? Results From a Cluster-Randomized Trial of Oral Cholera Vaccine in Kolkata, India. [PDF]

Open Forum Infect Dis
Im J, Islam MT, Ahmmed F, Kim DR, Tadesse BT, Kang S, Khanam F, Chowdhury F, Ahmed T, Firoj MG, Aziz AB, Hoque M, Jeon HJ, Kanungo S, Dutta S, Zaman K, Khan AI, Marks F, Kim JH, Qadri F, Clemens JD.   +20 more
europepmc   +1 more source

Challenges with achieving and maintaining oral cholera vaccine coverage: insights from serial cross-sectional representative surveys in a cholera-endemic community in the Democratic Republic of the Congo. [PDF]

BMJ Public Health
Koyuncu A, Bugeme PM, Dent J, Hutchins C, Xu H, Gallandat K, Cumming O, Matundanya J, Cikomola A, Rukakiza D, Nkombo M, Mufitini JS, Bashige Rumedeka B, Akilimali L, Lee EC, Welo PO, Knee J, Azman AS, Malembaka EB.   +18 more
europepmc   +1 more source

Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: A matched case-control study

, 2023
Malembaka EB, Bugeme PM, Hutchins C, Xu H, Hulse JD, Demby MN, Gallandat K, Saidi JM, Rumedeka BB, Itongwa M, Tshiwedi-Tsilabia E, Kitoga F, Bodisa-Matamu T, Kavunga-Membo H, Bengehya J, Kulondwa J, Debes AK, Taty N, Lee EC, Lunguya O, Lessler J, Leung DT, Cumming O, Okitayemba PW, Mukadi-Bamuleka D, Knee J, Azman AS.   +26 more
europepmc   +1 more source

Cholera vaccines for the rich, cholera for the poor: While the global cholera vaccine stockpile runs dry, a booming market for high-income countries exemplifies the chasm between commercial interests and global health needs. [PDF]

PLOS Glob Public Health
Houston AR, Houston S.
europepmc   +1 more source

Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti. [PDF]

Int J Infect Dis
Matias WR, Guillaume Y, Cene Augustin G, Vissieres K, Ternier R, Slater DM, Harris JB, Franke MF, Ivers LC.   +8 more
europepmc   +1 more source